Similar articles

• Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.

  Hatoum H, Crestanello JA, Dasi LP. Hatoum H, et al. N Engl J Med. 2016 Apr 21;374(16):1591. doi: 10.1056/NEJMc1600179. N Engl J Med. 2016. PMID: 27096592 No abstract available.
• Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.

  Miljoen H, Van Herck P, Paelinck B. Miljoen H, et al. N Engl J Med. 2016 Apr 21;374(16):1590. doi: 10.1056/NEJMc1600179. N Engl J Med. 2016. PMID: 27096590 No abstract available.
• Reduced Leaflet Motion in Bioprosthetic Aortic Valves--The FDA Perspective.

  Laschinger JC, Wu C, Ibrahim NG, Shuren JE. Laschinger JC, et al. N Engl J Med. 2015 Nov 19;373(21):1996-8. doi: 10.1056/NEJMp1512264. Epub 2015 Oct 5. N Engl J Med. 2015. PMID: 26437127 No abstract available.
• Subclinical bioprosthetic aortic valve thrombosis: clinical and translational implications.

  Yanagawa B, Mazine A, Bhatt DL, Clavel MA, Côté N, Cheema AN, Pibarot P, Verma S. Yanagawa B, et al. Curr Opin Cardiol. 2017 Mar;32(2):137-146. doi: 10.1097/HCO.0000000000000373. Curr Opin Cardiol. 2017. PMID: 28030440 Review.
• Multidetector computed tomography to detect reversible subclinical aortic bioprosthetic valve thrombosis with high systolic gradients.

  Gałąska R, Kulawiak-Gałąska D, Fijałkowski M, Szurowska E, Gruchała M. Gałąska R, et al. Cardiol J. 2016;23(4):411-2. doi: 10.5603/CJ.2016.0057. Cardiol J. 2016. PMID: 27531491 Review. No abstract available.